Share:
Pune, India, March 03, 2021 (GLOBE NEWSWIRE) The global
plasma fractionation market size is expected to reach USD 48.55 billion by 2027, exhibiting a CAGR of 7.6% during the forecast period. The growing incidence of immunological disorders is expected to spur demand for the market, states Fortune Business Insights, in a report, titled Plasma Fractionation Market Size, Share & COVID-19 Impact Analysis, By Product (Immunoglobulin, Albumin, Coagulation Factors, Protease Inhibitors, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End-user (Hospitals & Clinics, Clinical Research Laboratories, and Others), and Regional Forecast, 2020-2027. The market size stood at USD 25.44 billion in 2019.
Notable Development: